Latest Share Chat

REMOVE ADS

Ekf Diagnostics Share News (EKF)

Ekf Diagnostics Information

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes

Get Live Data

25.90 0.70 (2.80%)

Bid:

25.40

Ask:

26.00

Spread: 0.60 (2.362%)

Market Cap: £111.47m

Last checked at -

Intraday Ekf Diagnostics Share Chart

REMOVE ADS

Ekf Diagnostics News

EKF Diagnostics Raises Funds In Placing As It Announces Acquisitions

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said it has entered into separate conditional agreements to buy US-based molecular diag...

EKF Diagnostics proposes acquisition of Selah Genomics and DiaSpect Medical

EKF Diagnostics has entered into conditional agreements to buy US-based Selah Genomics and Swiss firm DiaSpect Medical. The company has proposed rais...

EKF Diagnostics Acquires Separation Technology For USD4.0 Million

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Wednesday that it had acquired Florida-based Separation Technology Inc, which manufactures ...

EKF Diagnostics acquires diagnostics business

AIM-listed EKF Diagnostics Holdings, a point-of-care diagnostics business, has acquired Separation Technology, which manufactures in-vitro diagnostics...

EKF Diagnostics To Transfer Production Of Quo-Test, Quo-Lab

LONDON (Alliance News) - EKF Diagnostic Holdings PLC said Tuesday that it plans to transfer production of its Quo-Test and Quo-Lab analysers and reage...

EKF Diagnostics Confident For 2014 As It Swings To Profit

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Wednesday expressed confidence for a better performance in 2014, as it swung to a pretax profit ...

EKF Diagnostics Holdings Registers Diabetes Monitoring Technology In Mexico

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Tuesday that it had registered its Quo-Lab HbA1c analyser, which is used to monitor diabete...

STOCKS NEWS EUROPE-UK small caps close down 1.6 pct

The FTSE small cap index and junior-listed AIM shares close down 1.6 percent and 1.3 percent respectively, outperforming the mid-caps , down 1.1, but ...